Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

We prospectively evaluated the efficacy and safety of imatinib plus hydroxyurea in patients with progressive/recurrent meningioma. A total of 21 patients with progressive/recurrent meningioma were enrolled in this dual center, single-arm, phase II trial. All patients received 500 mg of hydroxyurea t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Reardon, David A., Norden, Andrew D., Desjardins, Annick, Vredenburgh, James J., Herndon, James E., Coan, April, Sampson, John H., Gururangan, Sridharan, Peters, Katherine B., McLendon, Roger E., Norfleet, Julie A., Lipp, Eric S., Drappatz, Jan, Wen, Patrick Y., Friedman, Henry S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3616615/
https://ncbi.nlm.nih.gov/pubmed/21938530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-011-0687-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados